Candriam Luxembourg S.C.A. »

Mbx Biosciences shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Mbx Biosciences (MBX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.8M 294k 29.85

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Alphabet Cap Stk Cl C (GOOG)
Gilead Sciences (GILD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
McKesson Corporation (MCK)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Palo Alto Networks (PANW)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
OrbiMed Advisors
NEA Management Company
Wellington Management Company
BlackRock
Deep Track Capital
NVP Associates
Vanguard Group
Braidwell
Vanguard Capital Management
Driehaus Capital Management
Aaron Wealth Advisors
Cormorant Asset Management
Citadel Advisors
Kynam Capital Management

View all funds holding Mbx Biosciences